Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial uses a nasogastric tube to deliver ketones continuously — how long would I likely need that tube in place, and what does that mean for my day-to-day comfort and mobility while hospitalized?
2. 2Since this is a Phase 4 trial, does that mean ketone treatment has already been tested for safety in earlier studies, and what do we currently know about its effects in people with acute heart failure or cardiogenic shock specifically?
3. 3The trial is measuring how consistently ketone levels stay within a target range — what happens if my levels go too high or too low during the infusion, and how closely would I be monitored?
4. 4Given that I'm dealing with decompensated heart failure, would standard treatments like IV diuretics or other medications already used for acute heart failure be a better first step before considering this trial?
5. 5What is it about my specific situation — whether it's the severity of my heart failure or risk of cardiogenic shock — that would make me a good or poor candidate for a study like this one?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.